<--- Back to Details
First PageDocument Content

Pre-Exposure Prophylaxis (PrEP): A primer for primary care providers Daily emtricitabine/tenofovir (Truvada®) is safe and effective for reducing the risk of HIV acquisition in sexually active men and women and injection

Add to Reading List

Source URL: www.sfcityclinic.org

Download Document from Source Website

File Size: 359,31 KB

Share Document on Facebook

Similar Documents